NMTC (NeuroOne Medical Technologies) Beginning Cash Position: $3.56 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NMTC NeuroOne Medical Technologies Corp NMTC
21 GF Score
Price $1.71
! 4 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies Beginning Cash Position?

NeuroOne Medical Technologies NMTC -4.74% 21 Beginning Cash Position is $3.56 Mil as of Mar. 2026. GuruFocus rates NMTC with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

NeuroOne Medical Technologies's Beginning Cash Position for the quarter that ended in Mar. 2026 was $3.56 Mil.

NeuroOne Medical Technologies's quarterly Beginning Cash Position declined from Sep. 2025 ($8.04 Mil) to Dec. 2025 ($6.57 Mil) and declined from Dec. 2025 ($6.57 Mil) to Mar. 2026 ($3.56 Mil).

NeuroOne Medical Technologies's annual Beginning Cash Position declined from Sep. 2023 ($8.16 Mil) to Sep. 2024 ($5.32 Mil) and declined from Sep. 2024 ($5.32 Mil) to Sep. 2025 ($1.46 Mil).

NeuroOne Medical Technologies Beginning Cash Position Related Terms

NeuroOne Medical Technologies Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for NeuroOne Medical Technologies's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuroOne Medical Technologies Beginning Cash Position Chart

NeuroOne Medical Technologies Annual Data
Trend Dec16 Dec17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.04 6.90 8.16 5.32 1.46

NeuroOne Medical Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.32 8.04 6.57 3.56
NMTC
21GF Score
NeuroOne Medical Technologies Corp NMTC
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroOne Medical Technologies Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $3.56 Mil mean?
NeuroOne Medical Technologies (NMTC) has a Beginning Cash Position of $3.56 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on NeuroOne Medical Technologies and its competitors.
Is NeuroOne Medical Technologies' Beginning Cash Position too high?
NeuroOne Medical Technologies' current Beginning Cash Position is $3.56 Mil. Overall, NeuroOne Medical Technologies has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does NeuroOne Medical Technologies' Beginning Cash Position compare to CSDX and IRIX?
NeuroOne Medical Technologies' Beginning Cash Position of $3.56 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on NeuroOne Medical Technologies and its competitors. NeuroOne Medical Technologies's current Beginning Cash Position is $3.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroOne Medical Technologies stock overvalued right now?
NeuroOne Medical Technologies (NMTC) has a current Beginning Cash Position of $3.56 Mil. The current Beginning Cash Position is $3.56 Mil. NeuroOne Medical Technologies' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For NeuroOne Medical Technologies (NMTC), the current Beginning Cash Position is $3.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
21GF Score

Get the complete analysis for NMTC

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.71
Price